Medy Tox Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medy Tox Inc with three other
companies in this sector in South Korea:
sales of 124.19 billion Korean Won [US$116.61 million]
Choong Ang Vaccine Laboratory
(37.90 billion Korean Won [US$35.59 million]
Cell Biotech Co ., Limited.
(58.28 billion Korean Won [US$54.72 million]
of which 88%
was Finished Products).
During the year ended December of 2016, sales at
Medy Tox Inc were 133.26 billion Korean Won (US$125.13 million).
increase of 50.6%
versus 2015, when the company's sales were 88.51 billion Korean Won.
This was the fifth consecutive year of sales increases at Medy Tox Inc
(and since 2011, sales have increased a total of 514%).